TrialBMC cancer2020

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.

Hideaki Bando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.